title: The place of pelvic exenteration in surgical management of advanced and recurrent pelvic tumors.
abstract: A series of 28 exenterations for advanced pelvic tumours is presented. The operative mortality (within 90 days) was 17.8%. The actuarial survival (expressed as a two-year disease-free interval) was 35.7%, and better in cases with negative lymph nodes. The types of urinary and bowel diversions adopted are discussed in terms of longer survival.
authors.affiliation: Department of Gynaecology and Obstetrics, University of Turin, Italy.
authors.forename: F
authors.initials: F
authors.lastname: D'Addato
authors.forename: E
authors.initials: E
authors.lastname: Guercio
authors.forename: A
authors.initials: A
authors.lastname: Re
authors.forename: M
authors.initials: M
authors.lastname: Gatti
authors.forename: M
authors.initials: M
authors.lastname: Raspollini
authors.forename: D
authors.initials: D
authors.lastname: Proserpio
authors.forename: R
authors.initials: R
authors.lastname: Bellino
authors.forename: A
authors.initials: A
authors.lastname: Lanza
mesh_terms: D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000601:surgery*; D010385:Pelvic Exenteration / Q000379:methods / Q000401:mortality; D010386:Pelvic Neoplasms / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D012086:Reoperation